General anxiety disorder. Bah. People are stressed out, that's all - it's unlikely there is any organic cause that would have to be treated by drugs. So instead of trying to figure out how to make the society more human-friendly, just label the symptoms as a "disorder" and drug the affected humans back to the required level of happiness and productivity. And drug their unruly kids (for whom they don't have enough time because they have to make their current owners^H^H^H^H^H^Hemployers richer) back to the required level of obedience. Pharm-corps 2, humans 0, the game continues, the show must go on. ---------- Forwarded message ---------- Date: Sat, 17 May 2003 14:55:11 -0700 Subject: Censored Alerts From: Peter Phillips <peter.phillips@SONOMA.EDU> To: project-censored-L@SONOMA.EDU, prime@freespeech.org, dansc@yahoogroups.com Cc: censored2@SONOMA.EDU, censored@SONOMA.EDU Project Censored: An Inside Look at Independent News Edited by Katie Sims <SNIP> Inventing Disorders Pharmaceutical companies are on a quest to find a mental illness, sponsor public awareness campaigns for the disease, and to sell the drug to cure it, according to investigative journalist Brendan Koerner. Such a quest required precise strategies to seek FDA approval of a drug for new uses while increasing the profile of a hidden epidemic named general anxiety disorder. Though marketing disease rather than selling a drug is not a recent development, Koerner argues that "for pharmaceutical companies, marketing existing drugs for new uses makes perfect sense" and that GlaxoSmithKline, manufacturer of the antidepressant Paxil, had executed covert maneuvers in inventing illnesses to boost revenue sales of their drug. The article suggests that the chronology of events is no accident. Paxil was approved for use around the time the Cohn & Wolf GAD ad campaign hit the streets. The Cohn & Wolf campaign put the disease in the public spotlight. Famous doctors and academics in the mental illness field were bribed to acknowledge the wide spread hidden epidemic. Popular press assisted in promoting the effectiveness of the drug. The success of the Cohn & Wolfe campaign is traced to the creation of supporting alliances and coalitions. They connect disease experts and researches on mental illnesses to journalists, effectively to aid the flow of disease awareness and validity of the ad campaigns. Synopsis: Daryl Khoo Source: Mother Jones, July/August 2002, "Disorders Made to Order" by Brendan I. Koerner <SNIP>